Rhythmocor injection 5ml/10 ampoules

Rhythmocor Composition:
active ingredients: magnesium salt 2,3,4,5,6-pentahydroxycaproic acid, potassium salt 2,3,4,5,6-pentahydroxycaproic acid; 1 ml magnesium salt of 2,3,4,5,6-pentahydroxycaproic acid in terms of 100% substance 0.0833 g, potassium salt of 2,3,4,5,6-pentahydroxycaproic acid in terms of 100% substance 0.0167 G;
excipients: sodium benzoate (E 211).

Indications

The drug is indicated as part of a complex treatment for cardiac arrhythmias, including those associated with intoxication with cardiac glycosides, with paroxysm of atrial fibrillation / flutter with normotahisistole of the ventricles, acute myocardial infarction, ventricular extrasystolic arrhythmia, reciprocal nodal tachycardia, “pirouette” tachycardia, especially in violations electrolyte metabolism (hypokalemia, hypomagnesemia).

The drug is used in the treatment of coronary heart disease (to reduce hypoxic and ischemic disorders of myocardial metabolism associated with insufficiency of coronary blood flow). The drug is used in the treatment of myocarditis and hypokalemia caused by the use of saluretic agents.

Contraindications

Hypersensitivity to the drug. Atrioventricular block III degree. Cardiogenic shock (systolic blood pressure in adults below 90 mm Hg. Art.). Coma of unknown etiology. Decompensated forms of diabetes. Acute and chronic renal failure II-IV degree. Addison’s disease. Hyperkalemia and hypermagnesemia.

Dosage & Administration

1-2 times a day, intravenously, by injection 5-10 ml, pre-diluted in 10 ml of isotonic sodium chloride solution or 5% glucose solution.

The medicament is also used intravenously drip: 5-20 ml of the drug is diluted in 50-400 ml of isotonic sodium chloride solution or 5% glucose solution. Usually the course of treatment is 10-14 days.